Home › Aneurysms › NCT06793059

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

Who can join

Ages 22 and older · All sexes

Inclusion Criteria:

* Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.

Exclusion Criteria:

Exclusion Criteria:

* Cannot provide consent or legally authorized representative not available to provide consent Criteria:

About the study

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

What is being tested

• SHIELD (device)

Sponsor: Jacobs institute · Participants: 10 · Started: Jan 1, 2025

Contact the study team

• Carlos Pena, PhD, MS · Phone: 2404810824

Official record on ClinicalTrials.gov — NCT06793059

Locations in the U.S.

Conditions

• Aneurysms

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.